Literature DB >> 1883657

Methadone levels and neonatal withdrawal.

G Mack1, D Thomas, W Giles, N Buchanan.   

Abstract

The purpose of this study was to observe the effects of methadone exposure in utero, with special reference to maternal and neonatal methadone concentrations and neonatal withdrawal. Two groups of mother-infant pairs were studied. In the first group, serum methadone concentrations were determined in infants at 1, 6 and 24 h after delivery. In the second group, blood was obtained at 24, 48, 72 and 96 h after birth. There was no correlation between neonatal serum levels and the intensity of withdrawal symptoms. There was no relationship between maternal methadone dose at delivery or maternal serum levels and neonatal methadone levels. The results of this study may be complicated by the prenatal exposure of the neonates to other drugs of abuse apart from methadone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1883657     DOI: 10.1111/j.1440-1754.1991.tb00360.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  18 in total

1.  Can we use methadone for analgesia in neonates?

Authors:  S K Chana; K J Anand
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-09       Impact factor: 5.747

Review 2.  Pharmacological therapy for analgesia and sedation in the newborn.

Authors:  K J S Anand; R W Hall
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-11       Impact factor: 5.747

3.  Hyperphagia in neonates withdrawing from methadone.

Authors:  A Martinez; B Kastner; H W Taeusch
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

4.  Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.

Authors:  Ana de Castro; Hendreé E Jones; Rolley E Johnson; Teresa R Gray; Diaa M Shakleya; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2011-08       Impact factor: 3.681

5.  Infant autonomic functioning and neonatal abstinence syndrome.

Authors:  Lauren M Jansson; Janet A Dipietro; Andrea Elko; Martha Velez
Journal:  Drug Alcohol Depend       Date:  2010-03-01       Impact factor: 4.492

Review 6.  Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review.

Authors:  Erin Kelty; David B Preen
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

7.  Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome?

Authors:  C A Kuschel; L Austerberry; M Cornwell; R Couch; R S H Rowley
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-09       Impact factor: 5.747

8.  Cigarette Smoking and Neonatal Outcomes in Depressed and Non-Depressed Opioid-Dependent Agonist-Maintained Pregnant Patients.

Authors:  Margaret S Chisolm; Shauna P Acquavita; Karol Kaltenbach; Bernadette Winklbaur; Sarah H Heil; Peter R Martin; Susan M Stine; Mara Coyle; Jeannie-Marie S Leoutsakos; Michelle Tuten; Lauren M Jansson; Penina M Backer; Hendrée E Jones
Journal:  Addict Disord Their Treat       Date:  2011-12

9.  Outcomes of infants born to mothers receiving methadone for pain management in pregnancy.

Authors:  C Sharpe; C Kuschel
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-01       Impact factor: 5.747

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.